The global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032.

Market Lifecycle Stage

The global cell-based assay market is anticipated to witness growth during the forecast year 2023-2032, largely fuelled by the promise of a novel breakthrough in the cell-based assay market, which is no longer restricted to drug discovery. The foremost advantage of utilizing cell-based assays is apparent: unlike basic biochemical assays, they provide a more comprehensive representation of biological systems as they encompass not just an isolated receptor or enzyme but all the organelles of a cell functioning as a single entity.

Impact

The impact analysis for the factors that significantly affect the market, namely, drivers, restraints, and opportunities, has been evaluated on a short-term and long-term basis. The short-term assessment considers the period between 2022 and 2026, and the long-term assessment considers the period between 2027 and 2032.

Key developments and strategies that have been undertaken by some of the key players in this market have been accounted for evaluation of the impact analysis. Further, these key developments have been assessed to understand the future scope of integrating advancing technologies to enable superior outcomes.

Impact of COVID-19

The cell-based assay market has also been impacted by the pandemic. As per World Health Organization (WHO), COVID-19 has affected millions of people, resulting in a considerable number of deaths. In response, companies have intensified their research and development efforts to create vaccines and treatments for the SARS-CoV-2 virus. This research is considered critical and has remained unaffected, with operations and output continuing as before. As a result of the increase in research activities, the availability of research funding and demand for cell-based test products are expected to expand.

Companies in the industry are adapting their long-and short-term growth strategies to capitalize on opportunities in the research market by introducing innovative products to combat the pandemic. The need for COVID-19 research has created a broad scope for cell-based tests in viral infection research, vaccine development, and drug discovery.

Various COVID-19 vaccines and antiviral medications have been authorized or are under development, and patients are being treated symptomatically. The functional efficiency of the antibodies produced to neutralize the virus is assessed using cell-based assays for both vaccines and treatments. In order to reduce time and increase throughput, cell-based assays are utilized. As a result, the demand for cell-based assays to provide early indications of symptoms in patients has increased. Consequently, the overall

Impact of COVID-19

on the cell-based assay market is predicted to be positive.

Market Segmentation:

Global Cell-Based Assay Market

Segmentation 1: by Product

• Consumables
• Instruments and Software
• Services

Based on product type, the global cell-based assay market is segmented into consumables, instruments and software, and services.

Segmentation 2: by Region
• North America
• Europe
• Asia-Pacific
• Rest-of-the-World

In 2022, the North America region dominated the global cell-based assay market, and it is expected to hold its dominance throughout the forecast period 2023-2032.

Segmentation 3: by Application

• Drug Screening
• Basic Research
• Predictive Toxicology
• Other Applications (Other Industries, Cell and Gene therapy, among others)

As of 2022, the cell-based assay market (by application) was dominated by drug screening applications, holding a 41.27% market share.

Segmentation 4: by Technology

• Flow Cytometry
• Automated Handling
• High Throughput Screening
• High Content Screening
• Other Technologies (Label-Free Detection, Image Cytometry, among others)

As of 2022, the global cell-based assay market (by technology) was dominated by flow cytometry, holding a 34.11% market share.

Segmentation 5: by End User

• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Other End Users (Government Organizations)

As of 2022, the global cell-based assay market (by end user) was dominated by the pharmaceutical and biopharmaceutical companies’ segment, holding a 51.36% market share.

Segmentation 6: by Company

• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Corning Incorporated
• Lonza Group AG
• Agilent Technologies, Inc.
• Promega Corporation
• PerkinElmer, Inc.
• Eurofins DiscoverX Products
• Cell Signaling Technology, Inc.
• Charles River Laboratories International, Inc.
• Laboratory Corporation of America Holdings

Based on company, the global cell-based assay market is dominated by Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, among others.

Recent Developments in the Global Cell-Based Assay Market

• In April 2022, Lonza Group AG announced an enhancement to its automated cell therapy manufacturing system called the Cocoon Platform. The latest addition, known as magnetic selection, broadens the platform’s capabilities by enabling cell binding, separation, and bead removal (if needed), all conducted through the Cocoon cassette.

• In April 2020, Bio-Rad Laboratories, Inc. completed the acquisition of Celsee, Inc., a company that provides instruments and consumables that enable the isolation, detection, and analysis of individual cells.

• In July 2021, PerkinElmer, Inc. announced that it had reached a definitive agreement to acquire BioLegend, a manufacturer of high-quality antibodies and reagents used in biomedical research, for $5.25 billion.

• In April 2021, Lonza Group AG and Junshi Biosciences announced an expansion of their collaboration aimed at developing and manufacturing biologics. Lonza Group AG would utilize its worldwide network and local operational expertise to help Junshi Biosciences speed up the development of drugs in its pipeline and increase their adoption in the global market. According to the agreement, Lonza Group AG would provide comprehensive assistance, including cell line creation and development, the supply of cell culture media and reagents, process development, and GMP manufacturing.

• In July 2021, Lonza Group AG and CN Bio established a distribution agreement that involves Lonza Group AG providing hepatic cells to CN Bio for prequalification, which would be utilized in their PhysioMimix single-and multi-organ MPS technology. This collaboration aims to revolutionize the generation of preclinical data that is relevant to humans. By using prequalified cells, customers can avoid the need to experiment with multiple cell types, thereby saving time and ensuring the discovery of cells that will grow and function effectively in 3D culture.

Demand – Drivers and Limitations

The following are the demand drivers for the global cell-based assay market:

• Increase in Demand for Cell-Based Assay in Drug Discovery and Development
• Rise in Life Sciences Research Investments
• Technological Advancements

The market is expected to face some limitations due to the following challenges:

• High Cost
• Lack of Standardization

How can this report add value to an organization?

Workflow/Innovation Strategy: The global cell-based assay market is segmented (by product) into three categories, i.e., consumables, instruments and software, and services. The consumables segment is further classified as reagents, assay kits, microplates, cell lines, probes and labels, and other consumables.

Reagents accounted for 29.43% of the share in the global cell-based assay market from 2022 to 2032.

Growth/Marketing Strategy: The global cell-based assay market is anticipated to witness growth during the forecast year 2023-2032. The advent of CRISPR/Cas9 technology has completely transformed gene studies and their functions by offering highly precise and user-friendly genome editing capabilities. CRISPR significantly streamlines the development of more intricate disease-related cell-based assays, enabling researchers to tackle complex questions and study heterogeneous diseases with more relevant and sophisticated assays.

Competitive Strategy: Key players in the global cell-based assay market have been analyzed and profiled in the study, including manufacturers involved in new product development, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global cell-based assay market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

The post Global Cell-Based Assay Market – A Global and Regional Analysis: Focus on Product, Services, Application, End User, Technology, Regional Analysis, and Competitive Landscape – Analysis and Forecast, 2023-2032 first appeared on CRI Report.

Market Forecast

The global ready mix concrete market is estimated to record a healthy CAGR of 8.3% to surpass the market worth of USD 1,179.3 million by the review period of 2021 to 2027.

Ready mix concrete is by a long shot the most widely known type of concrete, representing almost 3/4 of all concrete. Producing ready-mix concrete and conveying it through a travel mixer empowers the execution of exact concrete in the development project, making it solid, solid, and dependable. Ready-mix concrete is especially profitable when little amounts of concrete or discontinuous putting of concrete are required.

Ready-mixed concrete is likewise great for enormous positions where space is restricted and there is no place for a mixing plant and total reserves. The market is exceptionally unique and is supposed to observe high development over the gauge period.

The worldwide ready-mix concrete market has characterized by sorts of RMCs, for example, travel mixed concrete, shrivel mixed concrete, and focal mixed concrete that is delivered nearby and off-site for applications in business, private, framework, and modern areas.

Market Segmentation

Global Ready-Mix Concrete Market is classified in terms of product type, production, and application.
Based on Product Type the market is classified in terms of Transit Mixed Concrete, Shrink Mixed Concrete, and Central Mixed Concrete. By Production, the market is bifurcated into On-Site and Off-Site. Global Ready-Mix Concrete Market, by Application, has been classified into Residential buildings, Commercial buildings, Industrial, and Infrastructure.

Regional Analysis

North America accounted for the second biggest offer in the market for ready-mix concrete with an expected to CAGR of 8.3% over the estimated period. Expanding redesigns in the US and Canada are projected to help the interest for ready-mix concrete in development tasks. Development spending in the U.S. has been essentially expanding lately.

The critical ascent in natural worries in the US is likewise expected to increment interest for climate well-disposed development concrete, for example, ready-mix concrete in the development business. Canada’s ready-mix concrete market is supposed to become fundamentally attributable to a sped-up development movement with huge interests in the lodging area, upheld by higher public spending on foundation and clean energy projects.

The Canadian government’s endeavors to accelerate its drawn-out foundation plan, the ‘Putting resources into Canada Plan, allots US$2 billion for clean energy projects, US$1.6 billion for broadband, US$1.6 billion for building retrofits, US$1.2 billion for farming water system projects and US$1.2 billion for electric transports and charging framework ill essentially drive the development exercises in the country.

Asia Pacific ruled the market for ready-mix concrete by creating most of the income shares and is expected to rise at an income-based- CAGR of 8.7% over the conjecture period. Fast infrastructural advancement in Thailand, Singapore, India, and China is projected to help the interest for ready-mix concrete in development tasks.

Government changes to foster the street framework in China and India to thrive the modern advancement in the locale are expected to affect the business emphatically. New development connected with plants and modern focuses in the district combined with the metropolitan turn of events and lodging development projected to flood the interest for ready-mix concrete.

Key Players

The key players in the global ready-mix concrete market are ACC LIMITED, Vicat SA, LafargeHolcim Ltd, Barney & Dickenson Inc., R. W. Sidley, Inc., CEMEX S.A.B. de C.V., HeidelbergCement AG, UltraTech Cement Ltd, U.S. Concrete, Inc., LIVINGSTON’S CONCRETE SERVICE, INC., Vulcan Materials Company, and Martin Marietta Materials, Inc.

The post Ready-Mix Concrete Market – Forecast till 2027 first appeared on CRI Report.

The Global Pharmacogenomics Market Research Report Forecast 2021-2029 is a valuable source of insightful data for business strategists. It provides the Pharmacogenomics industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Pharmacogenomics market study provides comprehensive data which enhances the understanding, scope and application of this report.

Key Players

Abbott Laboratories, Admera Health, Dynamic DNA Laboratories, Empire Genomics, LLC., F. Hoffmann-La Roche Ltd., Illumina, Inc., OneOme, LLC, Myriad Genetics Inc., OPKO Health, Inc. (GeneDx.), Thermo Fisher Scientific, Inc.

Comprehensive analysis in the report

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Global Pharmacogenomics Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

Global Pharmacogenomics Market: Product Segment Analysis

Polymerase Chain Reaction
Microarray
Sequencing
Mass Spectrometry
Electrophoresis
Others

Global Pharmacogenomics Market: Application Segment Analysis

Cardiovascular disease
Infectious diseases
Oncology
Neurological diseases
Psychiatry
Others

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward-looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Global Radiopharmaceutical Theranostics Market 2029

The post Global Pharmacogenomics Market 2029 first appeared on CRI Report.

Drivers
• Growing health consciousness
In the intensely challenging pharmaceutical packaging industry, increased safety awareness and the need for convenience in particular demands continuous assurance and difference through the production of new product content. The increasing awareness of environmental concerns and the introduction of new packaging recycling regulatory requirements also serve as the growing agents for the pharmaceutical packaging industry.
Restraints
• Improper knowledge and inadequate resources.
Poverty, lack of adequate infrastructure, low literacy rates, and the proliferation in emerging markets of inappropriate health systems hinder the market growth. Within developing countries, poverty constitutes a major obstacle in accessing health care facilities. The major force that impedes access to healthcare services is the financial constraints, poor information, obsolete facilities, the lack of sufficient personnel and improper knowledge of good healthcare practices.
Global Pharmaceutical packaging Market: Regions
In terms of value and volume, North America was the largest market accounting for XX% of total market volume share in 2019
North America maintained its hegemony in the global Pharmaceutical packaging market in 2019 owing to key pharmaceutical players in countries like USA, Mexico and Canada. These players make a high investment in pharmaceutical products due to government regulations and drive towards increased mortality and high life expectancy rates. High per capita income leads to better standards of living which demand a potential health care system. This has led to huge investment in the pharmaceutical packaging market and major players have emerged who specializes in such sectors.

APAC’s market demand is powered by rising governmental policies in the global pharmaceutical industry, increasing contract manufacturing activities, growing population aging, and increased health care expenditure. China has emerged as the major player in APAC region. However, consistent economic growth coupled with high population growth led to a rise in demand in countries like India, Brazil, etc.
Global Pharmaceutical packaging Market: Key Players

• Amcor plc
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• AptarGroup Inc.
• Dickinson and Company
• Berry Global Inc.
• International Paper Company
• Vetter Pharma International
• Becton
• West Pharmaceutical Services Inc.
• WestRock Company
• CCL Industries Inc.
• Schott AG
• Comar LLC
• Gerresheimer AG
• Other prominent players

Global Pharmaceutical packaging market report also contains analysis on:

• Pharmaceutical packaging Market Segments:
o By Production Process:
 Reusable
 Biodegradable
 Recyclable
o By End User Vertical:
 Food & Beverage
 Pharmaceutical & Medical
 Industrial
• Pharmaceutical packaging Market Dynamics
• Pharmaceutical packaging Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

The post Global Pharmaceutical Packaging Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030 first appeared on CRI Report.